Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

Black patients tend to experience more aggressive instances of MS and face greater barriers to diagnosis and treatment.

Historically, optic nerve involvement has been excluded from MS diagnostic criteria, but its inclusion in the new iteration ...

Multiple sclerosis is an incurable condition that can occur at any point in life However it is most common in young adults – ...

Fenebrutinib helped patients with relapsing forms of MS remain nearly free of relapses and disability progression up to two ...

Researchers still don’t fully understand the cause of multiple sclerosis or why the rate of progression is so difficult to ...

Roche has shared positive new 96-week data for its investigational fenebrutinib in patients with relapsing forms of multiple ...

Around 150,000 people are living with the condition in the UK, while a further 7,100 are newly diagnosed each year ...

Researchers from University of California San Diego School of Medicine have discovered that children living with multiple ...

Roche shares new data showing its MS drug fenebrutinib maintained low relapse rates and no disability progression in patients ...

While MS is still considered rare in India, we’re now seeing a shift toward moderate prevalence,” Dr M V Padma told Business ...